Streetbeat News

Analyst Ratings

SILK

Stifel analyst Rick Wise has upgraded Silk Road Medical (NASDAQ:SILK) from Hold to Buy and increased the price target from $9 to $20, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 9:49 am

GENI

Needham analyst Bernie McTernan has reiterated a Buy rating on Genius Sports (NYSE:GENI) and maintained a $9 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 9:46 am

ROKU

Seaport Global analyst David Joyce has upgraded Roku (NASDAQ:ROKU) from Sell to Neutral, indicating a change in the firm's outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 9:40 am

TSM

Needham analyst Charles Shi maintains a Buy rating on Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) and raises the price target from $115 to $133, suggesting an 18% upside. TSMC's stock surged nearly 10% on Thursday. Shi predicts TSMC will beat and raise expectations in an upcycle, with significant improvements expected in 2025. The transition to 3nm tech and the Arizona plant's potential early production are key factors. Shi is cautious about the end of the automotive inventory correction but expects TSMC's auto sector growth to support revenue independently.

Portfolio Pulse from Shanthi Rexaline

January 19, 2024 | 9:39 am

SUN

Raymond James analyst Justin Jenkins has maintained an Outperform rating on Sunoco (NYSE:SUN) and increased the price target from $55 to $65.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 9:38 am

OKE

Raymond James analyst Justin Jenkins has maintained an Outperform rating on ONEOK (NYSE:OKE) and increased the price target from $80 to $85.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 9:37 am

EE

Raymond James analyst Justin Jenkins has maintained an Outperform rating on Excelerate Energy (NYSE:EE) but has reduced the price target from $26 to $24.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 9:35 am

RWT

Raymond James analyst Stephen Laws has maintained a Strong Buy rating on Redwood Trust (NYSE:RWT) but has reduced the price target from $9 to $8.5.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 9:32 am

PLBC

Raymond James analyst David Feaster has maintained an Outperform rating on Plumas Bancorp (NASDAQ:PLBC) and increased the price target from $38 to $40.

Portfolio Pulse from Benzinga Newsdesk

January 19, 2024 | 9:30 am

FITB

Fifth Third Bancorp (NASDAQ:FITB) is set to release Q4 earnings on Jan. 19, 2023, with expected earnings of 85 cents per share, down from $1.00 year-over-year, and projected revenue of $2.16 billion, down from $2.32 billion. The company has seen recent executive appointments and a 1.6% share price drop to $33.24. Analysts have provided mixed ratings and price targets, with the most recent being a downgrade to Market Perform with a $37 target by Keefe, Bruyette & Woods.

Portfolio Pulse from Avi Kapoor

January 19, 2024 | 9:14 am